Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study. (Q52880828)
Jump to navigation
Jump to search
scientific article published on 14 March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study. |
scientific article published on 14 March 2016 |
Statements
Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study. (English)
1 reference
F V Michelis
1 reference
S Couban
1 reference
J Frazer
1 reference
S Shivakumar
1 reference
D E Hogge
1 reference
C L Toze
1 reference
W Rajkhan
1 reference
H J Kim
1 reference
A Daly
1 reference
J Slaby
1 reference
J Finke
1 reference
T Kiss
1 reference
C Bredeson
1 reference
M Sabloff
1 reference
D Sheppard
1 reference
M Bakkar
1 reference
M Brune
1 reference
D A Wall
1 reference
K Paulson
1 reference
G Popradi
1 reference
I Walker
1 reference
H A Messner
1 reference
14 March 2016
1 reference
51
1 reference
1019-1021
1 reference
7
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference